ProofPilot

ProofPilot

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.proofpilot.com

Last Round

Early Funding

Sep 24, 2025

Est. Valuation

$4.5M

Total Funding Raised

$23.4M

Momentum Score

25 /100

Company Overview

ProofPilot, Inc. provides a Software as a Service (SaaS) based Clinical Experience Platform (CXP) called StudyCoPilot, designed to modernize and automate the clinical trial process. Founded in 2014 and headquartered in New York, the company's platform orchestrates and simplifies tasks, communication, and workflows for all stakeholders, including sponsors, research sites, and patients. By eliminating guesswork and reducing protocol deviations, ProofPilot aims to improve recruitment and retention, enhance data quality, and streamline the overall trial experience. The company serves the life sciences, pharmaceutical, and wellness industries and is backed by venture capital, having completed multiple funding rounds including a Series C in July 2024.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Workflow Automation, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical experience platformCXPclinical trial automationdecentralized clinical trialspatient engagement platformCTMSclinical trial softwareeClinicaldigital protocol automationvirtual clinical trialsclinical trial intelligencepatient recruitmentStudy CoPilotpredictive analyticswearable sensor integrationEMR integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProofPilot Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ProofPilot Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 24, 2025
Series CJul 11, 2024
Series BApr 4, 2022
SeedMay 10, 2016
SeedNov 3, 2014

Key People

Founding team and executive leadership

Brian O'Neill

Chief Technology Officer

Executive Team

Matt Patras

Chief Financial Officer

Executive Team

ProofPilot Investors

Notable investors and investment history

InvestorRounds
Sopris CapitalSeries B, Series C
Cue BallSeed
First Trust Capital PartnersEarly Funding, Series B
Brooklyn Bridge VenturesSeed
Sopris Capital AssociatesEarly Funding
Big Red VenturesSeries C
Blueprint HealthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2025

    $7.7M raised in early funding.

  • Sep 16, 2025

    Acquired Lokavant, a clinical trial intelligence company.

ProofPilot Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProofPilot Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProofPilot's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range37
Year Founded2014
Last FundingSep 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.